Rubicon Research Ltd.

NSE: RUBICON | BSE: 544578 | ISIN: INE506V01022 | Industry: Pharmaceuticals
| Expensive Star
1674.8000 3.60 (0.22%)
NSE Sep 23, 2026 15:31 PM
Volume: 600.6K
 

logo
Rubicon Research Ltd.
13 Nov 2025
1674.80
0.22%

Outperformance across metrics; stellar start to the post-IPO phase

buy
by Motilal Oswal
Target: 780
Motilal Oswal
Rubicon Research (Rubicon) delivered better-than-expected performance, with a 7%/18%/21% beat on revenue/EBITDA/PAT for the quarter.
 
Rubicon Research has gained 245.32% in the last 1 Year
More from Rubicon Research Ltd.
Recommended
Big names, uneven returns: What drove India’s business groups over the year
The Baseline | 23 Sep 2026, 05:17PM
Market closes higher as Brent crude trades below $100
Trendlyne Marketwatch | 23 Sep 2026, 04:06PM
Five stocks to buy from analysts this week - September 22, 2026
The Baseline | 22 Sep 2026, 05:51PM